{"url_path":"/sec/nrxs/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1933567/0001493152-26-022384-index.html","accession_number":"0001493152-26-022384","cik":"0001933567","ticker":"NRXS","issuer_name":"Neuraxis, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1933567/0001493152-26-022384-index.html","primary_entity_key":"0001933567","primary_entity_name":"Neuraxis, INC"},"word_count":47,"has_tables":true,"body_markdown":"**ITEM\n5: OTHER INFORMATION.**\n\n \n\n*Insider\nTrading Arrangements and Policies*\n\n \n\nDuring\nthe quarter ended March 31, 2026, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement”\nor “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K."}